uniQure (QURE) Accumulated Expenses (2015 - 2026)
uniQure (QURE) posted quarterly Accumulated Expenses of $51.1 million for Q2 2026, up 62.44% year-over-year from $31.5 million in Q2 2025, and up 18.36% quarter-over-quarter from $43.2 million in Q1 2026.
Analysis
uniQure (QURE) Accumulated Expenses (2015 - 2026) Analysis & Trends
uniQure's Accumulated Expenses history runs 12 years deep, the most recent figure standing at $51.1 million for Q2 2026.
- In Q2 2026, Accumulated Expenses rose 62.44% year-over-year to $51.1 million; the TTM figure through Jun 2026 stood at $51.1 million (up 62.44% YoY), while the FY2025 annual figure was $41.3 million, up 41.29% from the prior year.
- Accumulated Expenses for Q2 2026 stood at $51.1 million, up from $43.2 million in the prior quarter.
- The five-year high for Accumulated Expenses was $51.9 million in Q3 2025, with the low at $1.4 million in Q4 2023.
- The 5-year median for Accumulated Expenses is $27.9 million (2023), against an average of $29.6 million.
- The sharpest annual moves came in 2023 and 2024: Accumulated Expenses slumped 95.42% in 2023, then jumped 1987.5% in 2024.
- uniQure's Accumulated Expenses stood at $30.6 million in 2022, then plunged by 95.42% to $1.4 million in 2023, then surged by 1987.5% to $29.2 million in 2024, then surged by 41.29% to $41.3 million in 2025, then advanced by 23.83% to $51.1 million in 2026.
- Business Quant data shows QURE's Accumulated Expenses at $51.1 million in Q2 2026, $43.2 million in Q1 2026, and $41.3 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 51.13 Mn |
| Mar 31, 2026 | 43.20 Mn |
| Dec 31, 2025 | 41.29 Mn |
| Sep 30, 2025 | 51.95 Mn |
| Jun 30, 2025 | 31.48 Mn |
| Mar 31, 2025 | 27.34 Mn |
| Dec 31, 2024 | 29.23 Mn |
| Sep 30, 2024 | 32.30 Mn |
| Jun 30, 2024 | 26.49 Mn |
| Mar 31, 2024 | 22.66 Mn |
| Dec 31, 2023 | 30.53 Mn |
| Sep 30, 2023 | 28.43 Mn |
| Jun 30, 2023 | 23.54 Mn |
| Mar 31, 2023 | 22.53 Mn |
| Dec 31, 2022 | 30.57 Mn |
| Sep 30, 2022 | 26.44 Mn |
| Jun 30, 2022 | 23.05 Mn |
| Mar 31, 2022 | 19.95 Mn |
| Dec 31, 2021 | 28.49 Mn |
| Sep 30, 2021 | 30.75 Mn |